These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 27528434)
1. Design, synthesis, and protein methyltransferase activity of a unique set of constrained amine containing compounds. Zhou H; Che X; Bao G; Wang N; Peng L; Barnash KD; Frye SV; James LI; Bai X Bioorg Med Chem Lett; 2016 Sep; 26(18):4436-4440. PubMed ID: 27528434 [TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of a Covalent Inhibitor of the SET Domain-Containing Protein 8 (SETD8) Lysine Methyltransferase. Butler KV; Ma A; Yu W; Li F; Tempel W; Babault N; Pittella-Silva F; Shao J; Wang J; Luo M; Vedadi M; Brown PJ; Arrowsmith CH; Jin J J Med Chem; 2016 Nov; 59(21):9881-9889. PubMed ID: 27804297 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and pharmacological evaluation of spirocyclic σ(1) receptor ligands with exocyclic amino moiety (increased distance 1). Rack E; Fröhlich R; Schepmann D; Wünsch B Bioorg Med Chem; 2011 May; 19(10):3141-51. PubMed ID: 21531141 [TBL] [Abstract][Full Text] [Related]
5. A novel approach applying a chemical biology strategy in phenotypic screening reveals pathway-selective regulators of histone 3 K27 tri-methylation. Liu Y; Platchek M; Kement B; Bee WT; Truong M; Zeng X; Hung S; Lin H; Morrow D; Kallal LA; Xie Q; Agarwal P; Pope AJ; Wu Z Mol Biosyst; 2014 Feb; 10(2):251-7. PubMed ID: 24257700 [TBL] [Abstract][Full Text] [Related]
6. Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3. James LI; Korboukh VK; Krichevsky L; Baughman BM; Herold JM; Norris JL; Jin J; Kireev DB; Janzen WP; Arrowsmith CH; Frye SV J Med Chem; 2013 Sep; 56(18):7358-71. PubMed ID: 24040942 [TBL] [Abstract][Full Text] [Related]
7. Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 inhibitors. Heinke R; Spannhoff A; Meier R; Trojer P; Bauer I; Jung M; Sippl W ChemMedChem; 2009 Jan; 4(1):69-77. PubMed ID: 19085993 [TBL] [Abstract][Full Text] [Related]
8. Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library. Shell DJ; Rectenwald JM; Buttery PH; Johnson RL; Foley CA; Guduru SKR; Uguen M; Rubiano JS; Zhang X; Li F; Norris-Drouin JL; Axtman M; Brian Hardy P; Vedadi M; Frye SV; James LI; Pearce KH SLAS Discov; 2022 Dec; 27(8):428-439. PubMed ID: 36272689 [TBL] [Abstract][Full Text] [Related]
9. Predicting and tuning physicochemical properties in lead optimization: amine basicities. Morgenthaler M; Schweizer E; Hoffmann-Röder A; Benini F; Martin RE; Jaeschke G; Wagner B; Fischer H; Bendels S; Zimmerli D; Schneider J; Diederich F; Kansy M; Müller K ChemMedChem; 2007 Aug; 2(8):1100-15. PubMed ID: 17530727 [TBL] [Abstract][Full Text] [Related]
10. One-step synthesis of saturated spirocyclic N-heterocycles with stannyl amine protocol (SnAP) reagents and ketones. Siau WY; Bode JW J Am Chem Soc; 2014 Dec; 136(51):17726-9. PubMed ID: 25482378 [TBL] [Abstract][Full Text] [Related]
11. epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors. Mai A; Cheng D; Bedford MT; Valente S; Nebbioso A; Perrone A; Brosch G; Sbardella G; De Bellis F; Miceli M; Altucci L J Med Chem; 2008 Apr; 51(7):2279-90. PubMed ID: 18348515 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of SETD8 inhibitors. Ma A; Yu W; Xiong Y; Butler KV; Brown PJ; Jin J Medchemcomm; 2014 Dec; 5(12):1892-1898. PubMed ID: 25554733 [TBL] [Abstract][Full Text] [Related]
13. Discovery of thieno[3,2-c]pyridin-4-amines as novel Bruton's tyrosine kinase (BTK) inhibitors. Zhao X; Xin M; Wang Y; Huang W; Jin Q; Tang F; Wu G; Zhao Y; Xiang H Bioorg Med Chem; 2015 Sep; 23(17):6059-68. PubMed ID: 26277759 [TBL] [Abstract][Full Text] [Related]
14. Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening. Meng F; Cheng S; Ding H; Liu S; Liu Y; Zhu K; Chen S; Lu J; Xie Y; Li L; Liu R; Shi Z; Zhou Y; Liu YC; Zheng M; Jiang H; Lu W; Liu H; Luo C J Med Chem; 2015 Oct; 58(20):8166-81. PubMed ID: 26390175 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and identification of a new class of triarylmethyl amine compounds as inhibitors of apolipoprotein E production. Singh M; Schott JT; Leon MA; Granata RT; Dhah HK; Welles JA; Boyce MA; Oseni-Olalemi HS; Mordaunt CE; Vargas AJ; Patel NV; Maitra S Bioorg Med Chem Lett; 2012 Oct; 22(19):6252-5. PubMed ID: 22959206 [TBL] [Abstract][Full Text] [Related]
16. Chemogenetic analysis of human protein methyltransferases. Richon VM; Johnston D; Sneeringer CJ; Jin L; Majer CR; Elliston K; Jerva LF; Scott MP; Copeland RA Chem Biol Drug Des; 2011 Aug; 78(2):199-210. PubMed ID: 21564555 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anticholinesterase activity of novel benzylidenechroman-4-ones bearing cyclic amine side chain. Pourshojaei Y; Gouranourimi A; Hekmat S; Asadipour A; Rahmani-Nezhad S; Moradi A; Nadri H; Moghadam FH; Emami S; Foroumadi A; Shafiee A Eur J Med Chem; 2015 Jun; 97():181-9. PubMed ID: 25969170 [TBL] [Abstract][Full Text] [Related]
18. Symmetrical bis-tertiary amines as novel CXCR4 inhibitors. Bai R; Liang Z; Yoon Y; Liu S; Gaines T; Oum Y; Shi Q; Mooring SR; Shim H Eur J Med Chem; 2016 Aug; 118():340-50. PubMed ID: 27179215 [TBL] [Abstract][Full Text] [Related]
19. Novel pharmacological maps of protein lysine methyltransferases: key for target deorphanization. Rabal O; Castellar A; Oyarzabal J J Cheminform; 2018 Jul; 10(1):32. PubMed ID: 30032331 [TBL] [Abstract][Full Text] [Related]
20. 4-(4-morpholinophenyl)-6-arylpyrimidin-2-amines: synthesis, spectral analysis, and in vitro microbiological evaluation. Thanusu J; Kanagarajan V; Gopalakrishnan M J Enzyme Inhib Med Chem; 2010 Jun; 25(3):347-53. PubMed ID: 19874135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]